{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidlujoaqfev6yva7usfws7v44ftyvzgm5szhq74k6eyxexkzpcoo4",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mepbuop67ui2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreigug647bzud5lthbcrw2heh5sg4noj5l22k4b5vat3we7zprtttpa"
    },
    "mimeType": "image/jpeg",
    "size": 124666
  },
  "path": "/2026/02/12/moderna-stephen-hoge-interview-flu-vaccine/?utm_campaign=rss",
  "publishedAt": "2026-02-12T23:23:20.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "The Readout LOUD",
    "biotechnology",
    "infectious disease",
    "Moderna",
    "Pharmaceuticals",
    "STAT+",
    "Vaccines"
  ],
  "textContent": "In an interview, Moderna President Stephen Hoge took questions on an FDA decision on the biotech's mRNA flu vaccine, as well as the impact on the company and others in…",
  "title": "STAT+: Moderna’s president weighs in on FDA’s decision not to review its flu vaccine",
  "updatedAt": "2026-02-12T23:23:27.000Z"
}